205 related articles for article (PubMed ID: 18158123)
1. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
2. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
Marrari M; Duquesnoy RJ
Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
[TBL] [Abstract][Full Text] [Related]
3. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry.
Duquesnoy RJ; Marrari M; Tambur AR; Mulder A; Sousa LC; da Silva AS; do Monte SJ
Hum Immunol; 2014 Nov; 75(11):1097-103. PubMed ID: 25305456
[TBL] [Abstract][Full Text] [Related]
4. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
Duquesnoy RJ; Askar M
Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
[TBL] [Abstract][Full Text] [Related]
5. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
6. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
Wiebe C; Pochinco D; Blydt-Hansen TD; Ho J; Birk PE; Karpinski M; Goldberg A; Storsley LJ; Gibson IW; Rush DN; Nickerson PW
Am J Transplant; 2013 Dec; 13(12):3114-22. PubMed ID: 24164958
[TBL] [Abstract][Full Text] [Related]
7. Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
Kramer CSM; Bezstarosti S; Franke-van Dijk MEI; Vergunst M; Roelen DL; Uyar-Mercankaya M; Voogt-Bakker KH; Heidt S
HLA; 2024 Jan; 103(1):e15345. PubMed ID: 38239050
[TBL] [Abstract][Full Text] [Related]
8. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
9. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
[TBL] [Abstract][Full Text] [Related]
10. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
[TBL] [Abstract][Full Text] [Related]
11. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
[TBL] [Abstract][Full Text] [Related]
12. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
13. HLA epitope based matching for transplantation.
Duquesnoy RJ
Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
[TBL] [Abstract][Full Text] [Related]
14. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Flomenberg N; Baxter-Lowe LA; Confer D; Fernandez-Vina M; Filipovich A; Horowitz M; Hurley C; Kollman C; Anasetti C; Noreen H; Begovich A; Hildebrand W; Petersdorf E; Schmeckpeper B; Setterholm M; Trachtenberg E; Williams T; Yunis E; Weisdorf D
Blood; 2004 Oct; 104(7):1923-30. PubMed ID: 15191952
[TBL] [Abstract][Full Text] [Related]
15. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.
Bezstarosti S; Kramer CSM; Franke-van Dijk MEI; Vergunst M; Bakker KH; Uyar-Mercankaya M; Buchli R; Roelen DL; de Fijter JW; Claas FHJ; Heidt S
Front Immunol; 2021; 12():761893. PubMed ID: 35069533
[TBL] [Abstract][Full Text] [Related]
17. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
Duquesnoy RJ
Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
Front Immunol; 2021; 12():800946. PubMed ID: 35154076
[TBL] [Abstract][Full Text] [Related]
19. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
[TBL] [Abstract][Full Text] [Related]
20. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]